Login to Your Account

Biotech Foundations: MMRF Partners with Biotech to Speed Cancer Therapies R&D

By Catherine Shaffer

Tuesday, March 29, 2011
Not satisfied with merely providing early stage research support to fight cancer, the Multiple Myeloma Research Foundation has an "end-to-end" strategy for fostering drug development at every stage. The MMRF, headquartered in Norwalk, Conn., has served as midwife to four breakthrough therapies for multiple myeloma: Velcade, Thalomid, Revlimid and Doxil.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription